Azole Drugs Are Imported By Facilitated Diffusion in and Other Pathogenic Fungi

English version České info

Despite the wealth of knowledge regarding the mechanisms of action and the mechanisms of resistance to azole antifungals, very little is known about how the azoles are imported into pathogenic fungal cells. Here the in-vitro accumulation and import of Fluconazole (FLC) was examined in the pathogenic fungus, Candida albicans. In energized cells, FLC accumulation correlates inversely with expression of ATP-dependent efflux pumps. In de-energized cells, all strains accumulate FLC, suggesting that FLC import is not ATP-dependent. The kinetics of import in de-energized cells displays saturation kinetics with a K_m of 0.64 uM and V_max of 0.0056 pmol/min/10⁸ cells, demonstrating that FLC import proceeds via facilitated diffusion through a transporter rather than passive diffusion. Other azoles inhibit FLC import on a mole/mole basis, suggesting that all azoles utilize the same facilitated diffusion mechanism. An analysis of related compounds indicates that competition for azole import depends on an aromatic ring and an imidazole or triazole ring together in one molecule. Import of FLC by facilitated diffusion is observed in other fungi, including Cryptococcus neoformans, Saccharomyces cerevisiae, and Candida krusei, indicating that the mechanism of transport is conserved among fungal species. FLC import was shown to vary among Candida albicans resistant clinical isolates, suggesting that altered facilitated diffusion may be a previously uncharacterized mechanism of resistance to azole drugs.

Vyšlo v časopise: Azole Drugs Are Imported By Facilitated Diffusion in and Other Pathogenic Fungi. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001126
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001126

Souhrn

Zdroje

1. LaiCC

TanCK

HuangYT

ShaoPL

HsuehPR

2008 Current challenges in the management of invasive fungal infections. J Infect Chemother 14 77 85

2. PicazoJJ

Gonzalez-RomoF

CandelFJ

2008 Candidemia in the critically ill patient. Int J Antimicrob Agents 32 Suppl 2 S83 85

3. ClarkTA

HajjehRA

2002 Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15 569 574

4. TortoranoAM

KibblerC

PemanJ

BernhardtH

KlingsporL

2006 Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27 359 366

5. GreenspanD

GreenspanJ

SchiodtM

PindborgJ

1990 AIDS and the mouth. Copenhagen Munksgaard 91 102

6. MorschhauserJ

2002 The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587 240 248

7. WhiteTC

MarrKA

BowdenRA

1998 Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clinical Microbiology Reviews 11 382 402

8. SanglardD

WhiteTC

2005 Chapter 14 - Molecular Principles of Antifungal Drug Resistance.

HeitmanJ

FillerSG

EdwardsJE

MitchellAP

Molecular principles of fungal pathogenesis Washington, D.C. ASM Press 197 212

9. AlbertsonGD

NiimiM

CannonRD

JenkinsonHF

1996 Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrobial Agents & Chemotherapy 40 2835 2841

10. MaesakiS

MarichalP

Vanden BosscheH

SanglardD

KohnoS

1999 Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. Journal of Antimicrobial Chemotherapy 44 27 31

11. LambDC

KellyDE

ManningNJ

KellySL

1997 Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. Fems Microbiology Letters 147 189 193

12. SanglardD

KuchlerK

IscherF

PaganiJL

MonodM

1995 Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents and Chemotherapy 39 2378 2386

13. PrasadT

ChandraA

MukhopadhyayCK

PrasadR

2006 Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells. Antimicrob Agents Chemother 50 3597 3606

14. MukhopadhyayK

KohliA

PrasadR

2002 Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother 46 3695 3705

15. PasrijaR

KrishnamurthyS

PrasadT

ErnstJF

PrasadR

2005 Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. Journal Of Antimicrobial Chemotherapy 55 905 913

16. BoironP

DrouhetE

DupontB

ImprovisiL

1987 Entry of ketoconazole into Candida albicans. Antimicrob Agents Chemother 31 244 248

17. LyonsCN

WhiteTC

2000 Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrobial Agents and Chemotherapy 44 2296 2303

18. WhiteTC

1997 Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrobial Agents And Chemotherapy 41 1482 1487

19. YamazakiT

SanglardD

SatoY

ArasazaM

1998 Fluconazole (FCZ) treatment for murine systemic candidiasis with Candida ablicans null mutants of nultidrug resistance genes. Intersci Conf Antimicrob Agents Chemother: ASM 112 (abstract no. C-149)

20. NoelT

FrancoisF

PaumardP

ChastinC

BrethesD

2003 Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter. Antimicrob Agents Chemother 47 1275 1284

21. BourotS

KarstF

1995 Isolation and characterization of the Saccharomyces cerevisiae SUT1 gene involved in sterol uptake. Gene 165 97 102

22. National Center for Biotechnology Information N, NIH 2010 PubChem Compound. 2010. http://pubchem.ncbi.nlm.nih.gov/

23. KrausJM

VerlindeCL

KarimiM

LepeshevaGI

GelbMH

2009 Rational modification of a candidate cancer drug for use against Chagas disease. J Med Chem 52 1639 1647

24. SuryadevaraPK

OlepuS

LockmanJW

OhkandaJ

KarimiM

2009 Structurally simple inhibitors of lanosterol 14alpha-demethylase are efficacious in a rodent model of acute Chagas disease. J Med Chem 52 3703 3715

25. LampingE

MonkBC

NiimiK

HolmesAR

TsaoS

2007 Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell 6 1150 1165

26. NiimiM

WadaS

TanabeK

KanekoA

TakanoY

2005 Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae. Jpn J Infect Dis 58 1 7

27. Invitrogen 2010 Invitrogen Clones. 2010. http://clones.invitrogen.com/bacpacsearch.php

28. RaiborgC

StenmarkH

2009 The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458 445 452

29. NickersonDP

RussellMR

OdorizziG

2007 A concentric circle model of multivesicular body cargo sorting. EMBO Rep 8 644 650

30. TuchBB

GalgoczyDJ

HerndayAD

LiH

JohnsonAD

2008 The evolution of combinatorial gene regulation in fungi. PLoS Biol 6 e38

31. RokasA

HittingerCT

2007 Transcriptional rewiring: the proof is in the eating. Current Biology 17 R626 628

32. MartchenkoM

LevitinA

HoguesH

NantelA

WhitewayM

2007 Transcriptional rewiring of fungal galactose-metabolism circuitry. Current Biology 17 1007 1013

33. IhmelsJ

BergmannS

Gerami-NejadM

YanaiI

McClellanM

2005 Rewiring of the yeast transcriptional network through the evolution of motif usage. Science 309 938 940

34. WhiteTC

HollemanS

DyF

MirelsLF

StevensDA

2002 Resistance mechanisms in clinical isolates of Candida albicans. Antimicrobial Agents and Chemotherapy 46 1704 1713

35. JorgensenP

EdgingtonNP

SchneiderBL

RupesI

TyersM

2007 The size of the nucleus increases as yeast cells grow. Mol Biol Cell 18 3523 3532

36. NettJ

LincolnL

MarchilloK

MasseyR

HoloydaK

2007 Putative Role of {beta}-1,3 Glucans in Candida albicans Biofilm Resistance. Antimicrob Agents Chemother 51 510 520

37. Chapeland-LeclercF

BouchouxJ

GoumarA

ChastinC

VillardJ

2005 Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to Flucytosine and Fluconazole in Candida lusitaniae. Antimicrobial Agents and Chemotherapy 49 3101 3108

38. PaponN

NoelT

FlorentM

Gibot-LeclercS

JeanD

2007 Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance. Antimicrob Agents Chemother 51 369 371

39. MullerFM

StaudigelA

SalvenmoserS

TredupA

MiltenbergerR

2007 Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. Antimicrob Agents Chemother 51 3014 3016

40. EshelD

Ben-ArieR

DinoorA

PruskyD

2000 Resistance of Gibberellin-Treated Persimmon Fruit to Alternaria alternata Arises from the Reduced Ability of the Fungus to Produce Endo-1,4-beta-Glucanase. Phytopathology 90 1256 1262

41. NormanSM

BennettRD

PolingSM

MaierVP

NelsonMD

1986 Paclobutrazol Inhibits Abscisic Acid Biosynthesis in Cercospora rosicola. Plant Physiology 80 122 125

42. BayaM

SouloungangaP

GelhayeE

GerardinP

2001 Fungicidal activity of beta-thujaplicin analogues. Pest Manag Sci 57 833 838

43. RankinGO

YangDJ

Cressey-VenezianoK

WangRT

BrownPI

1985 In vivo and in vitro effects of azaconazole on renal function in the Fischer 344 rat. Toxicology 34 1 11

44. FonziWA

IrwinMY

1993 Isogenic strain construction and gene mapping in Candida albicans. Genetics 134 717 728

45. WhiteTC

PfallerMA

RinaldiRG

SmithJ

ReddingSW

1997 Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Diseases 3 S102 S109

46. HuaJ

MeyerJD

LodgeJK

2000 Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin Diagn Lab Immunol 7 125 128

47. OliverBG

SilverPM

MarieC

HootSJ

LeydeSE

2008 Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiology 154 960 970

48. MarieC

LeydeS

WhiteTC

2008 Cytoplasmic localization of sterol transcription factors Upc2p and Ecm22p in S. cerevisiae. Fungal Genet Biol 45 1430 1438

49. SongJL

HarryJB

EastmanRT

OliverBG

WhiteTC

2004 The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugs. Antimicrob Agents Chemother 48 1136 1144